The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

50 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.EBI
Universitat De Barcelona
Novel 11ß-HSD1 inhibitors: C-1 versus C-2 substitution and effect of the introduction of an oxygen atom in the adamantane scaffold.EBI
Universitat De Barcelona
Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity.EBI
Universitat De Barcelona
New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.EBI
Universitat De Barcelona
Azapropellanes with anti-influenza a virus activity.EBI
Universitat De Barcelona
Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targetingß-amyloid, tau, and cholinesterase pathologies.EBI
Universitat De Barcelona
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents withß-amyloid and tau anti-aggregating properties.EBI
Universitat De Barcelona
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.EBI
Universitat De Barcelona
Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.EBI
Universitat De Barcelona
1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.EBI
Universitat De Barcelona
Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.EBI
Universitat De Barcelona
New approach to measure protein binding based on a parallel artificial membrane assay and human serum albumin.EBI
Universitat De Barcelona
Modulation of binding strength in several classes of active site inhibitors of acetylcholinesterase studied by comparative binding energy analysis.EBI
Universitat De Barcelona
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.EBI
Universitat De Barcelona
Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease.EBI
Universitat De Barcelona
Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists.EBI
Universitat De Barcelona
Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system.EBI
Universitat De Barcelona
Binding of 13-amidohuprines to acetylcholinesterase: exploring the ligand-induced conformational change of the gly117-gly118 peptide bond in the oxyanion hole.EBI
Universitat De Barcelona
Synthesis, in vitro pharmacology, and molecular modeling of syn-huprines as acetylcholinesterase inhibitors.EBI
Universitat De Barcelona
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.EBI
Universitat De Barcelona
Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.EBI
Universitat De Barcelona
Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.EBI
Universitat De Barcelona
Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.EBI
Universitat De Barcelona
Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors.EBI
Universitat De Barcelona
Identification of novel indanylsulfonamide guanylhydrazones as potent 5-HT6 serotonin receptor antagonists.EBI
Universitat De Barcelona
Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.EBI
Universitat De Barcelona
N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum.EBI
Universitat De Barcelona
Resveratrol derivatives: Synthesis and their biological activities.EBI
Universitat De Barcelona
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space.EBI
Universitat De Barcelona
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.EBI
Universitat De Barcelona
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors.EBI
Universitat De Barcelona
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CBEBI
Universitat De Barcelona
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: EBI
Universitat De Barcelona
Discovery of a novel kinase hinge binder fragment by dynamic undocking.EBI
Universitat De Barcelona
Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.EBI
Universitat De Barcelona
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.EBI
Universitat De Barcelona
Multigram scale synthesis of polycyclic lactones and evaluation of antitumor and other biological properties.EBI
Universitat De Barcelona
Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors.EBI
Universitat De Barcelona
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.EBI
Universitat De Barcelona
3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.EBI
Universitat De Barcelona
Synthesis and biological properties of aryl methyl sulfones.EBI
Universitat De Barcelona
Design, synthesis and in vivo study of novel pyrrolidine-based 11β-HSD1 inhibitors for age-related cognitive dysfunction.EBI
Universitat De Barcelona
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus.EBI
Universitat De Barcelona
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- DioxygenaseBDB
Incyte
SHMT inhibitorsBDB
The Trustees of Princeton University
TYK2 inhibitors and uses thereofBDB
Nimbus Lakshmi
Isoquinoline derivatives as MGAT2 inhibitorsBDB
Merck Sharp & Dohme
Metalloenzyme inhibitor compoundsBDB
Innocrin Pharmaceuticals
Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors".BDB
Mcgill University
A practical synthesis of the major 3-hydroxy-2-pyrrolidinone metabolite of a potent CDK2/cyclin A inhibitor.BDB
Nerviano Medical Sciences